high credibilityNew England Journal of Medicine2023
NEJM SELECT trial: Semaglutide and cardiovascular outcomes in obesity
Lincoff AM et al.
nejm.org
high credibilitySource scorecard — credibility, citation history, and editorial transparency for this domain.
34
Citations
34
High credibility
0
Medium credibility
23
Theory pages
Cited-theory verdict breakdown
Debunked
9
Partially True
8
Unproven
3
Confirmed
3
Theory coverage
GLP-1 / Ozempic Side-Effect Suppression ClaimsGSK Avandia CV risk concealment (1999–2010)Fertility and Contraception Conspiracy ClaimsIvermectin as COVID-19 CureVioxx cardiovascular concealment (Merck, 1999-2004)Repatha and Statin Suppression ClaimsCancer-Clinic Suppression ClaimsAIDS DenialismBig Pharma and Suppressed Medical TreatmentsRFK Jr. anti-vaccine activism / Children's Health Defense (1998-present)Hydroxychloroquine COVID promotion and suppression (Mar-Jun 2020)Autism False Causes and CuresMMR Vaccine-Autism LinkCOVID Vaccine Depopulation ClaimsMeasles Vitamin A Treatment ClaimsBird Flu Plandemic ClaimsSeed-Oil Detox Cure ClaimsParasite Cleanse Cure NetworksMichael Jackson Death Conspiracy TheoriesOperation Ranch Hand / Agent Orange dioxin contamination concealment (1962-71)Prince's 2016 death: counterfeit pill murder vs accidental overdoseThe 2001 Anthrax LettersPfizer Documents Court Release: "FDA Was Hiding Vaccine Data"
high credibilityNew England Journal of Medicine2007
Nissen & Wolski: Rosiglitazone and cardiovascular events
Nissen SE, Wolski K
high credibilityNew England Journal of Medicine2021
Zauche et al.: mRNA COVID-19 vaccination and miscarriage risk (NEJM 2021)
Lauren Zauche et al.
high credibilityNew England Journal of Medicine2022
ACTIV-6 Trial: Effect of Ivermectin for Outpatient Treatment (NEJM)
Naggie et al.
high credibilityNew England Journal of Medicine2000
VIGOR trial: cardiovascular events in NEJM
Bombardier et al.
high credibilityNew England Journal of Medicine2017
FOURIER trial: evolocumab and cardiovascular outcomes (NEJM)
Sabatine et al.
high credibilityNew England Journal of Medicine2022
NEJM SURMOUNT-1: Tirzepatide for obesity treatment
Jastreboff AM et al.
high credibilityNew England Journal of Medicine2005
APPROVe trial: Vioxx and cardiovascular events
Bresalier et al.
high credibilityNew England Journal of Medicine1982
Moertel et al.: Clinical trial of amygdalin (Laetrile) in cancer patients (NEJM 1982)
Charles Moertel et al.
high credibilityNew England Journal of Medicine2018
ODYSSEY OUTCOMES trial: alirocumab after ACS (NEJM)
Schwartz et al.
high credibilityNew England Journal of Medicine1997
Hammer et al.: ACTG 320 triple-ARV trial (NEJM 1997)
Scott Hammer et al.
high credibilityNew England Journal of Medicine2008
Turner et al. NEJM: Publication bias in antidepressant trials
Erick Turner et al.
high credibilityNew England Journal of Medicine2022
TOGETHER Trial: Effect of Early Treatment with Ivermectin
Reis et al.
high credibilityNew England Journal of Medicine2003
Hviid et al. 2003 — thimerosal and autism, NEJM (n=530,000)
Anders Hviid et al.
high credibilityNew England Journal of Medicine2020
NEJM HCQ observational study retraction (June 5 2020)
Mehra et al.
high credibilityNew England Journal of Medicine2002
Madsen et al.: MMR and autism — Danish cohort study (NEJM 2002)
Kreesten Madsen et al.
high credibilityNew England Journal of Medicine2002
Madsen et al.: MMR vaccination and autism
Kreesten M. Madsen et al.
high credibilityNew England Journal of Medicine2021
Zauche et al.: mRNA vaccination and miscarriage risk (NEJM 2021)
Lauren Zauche et al.
high credibilityNew England Journal of Medicine2022
NEJM: Immune checkpoint inhibitor trials in solid tumours (review)
Various
high credibilityNew England Journal of Medicine2020
NEJM: Clinical review — measles
Peter Strebel et al.
high credibilityNew England Journal of Medicine1994
Connor et al.: ACTG 076 AZT mother-to-child transmission trial (NEJM 1994)
Edward Connor et al.
high credibilityNew England Journal of Medicine2024
NEJM: Human H5N1 infection case reports — US dairy farm workers 2024
NEJM
high credibilityNew England Journal of Medicine2016
NEJM: Dietary fat and cardiovascular risk — current evidence
Various authors
high credibilityNew England Journal of Medicine2021
WHO Solidarity trial: no mortality benefit from HCQ
WHO Solidarity Trial Consortium
high credibilityNew England Journal of Medicine2022
NEJM: TOGETHER trial — ivermectin vs placebo for COVID-19 (no benefit)
Reis et al.
high credibilityNew England Journal of Medicine2005
Propofol as anaesthetic: clinical use and risks
Various medical authors
high credibilityNew England Journal of Medicine2003
The Vietnam War and Agent Orange: health effects review
Various epidemiologists
high credibilityNew England Journal of Medicine2014
Statin-associated myopathy: clinical and genetic aspects (NEJM)
Stroes et al.
high credibilityNew England Journal of Medicine2017
Fentanyl toxicity: pharmacological overview
Various
high credibilityNew England Journal of Medicine2001
New England Journal of Medicine: Clinical Presentation and Diagnosis of Inhalational Anthrax
Mayer et al.
high credibilityNew England Journal of Medicine2021
Myocarditis after COVID-19 mRNA vaccination: safety surveillance
Oster et al.
high credibilityNew England Journal of Medicine2022
NEJM: Long-term safety of GLP-1 agonists — systematic review
Drucker DJ
high credibilityNew England Journal of Medicine2009
Effect of Rosiglitazone on the Frequency of Diabetes in Patients with Impaired Glucose Tolerance or Impaired Fasting Glucose (RECORD trial)
Philip D. Home et al.
high credibilityNew England Journal of Medicine2007
Rosiglitazone and Cardiovascular Risk
Bruce M. Psaty and Curt D. Furberg